Cara Therapeutics Stock Price (NASDAQ:CARA)

Add to My Stocks
$13.21 $0.16 (1.2%) CARA stock closing price Sep 20, 2017 (Closing)
Prev Close* : $13.37
Market Cap:
Day Low: $13.05
52 Week Low: $5.85
Open: $13.36
Volume: 653339
Day High: $13.54
52 Week High: $28.50

Cara Therapeutics Stock Articles & Video

more news on CARA stock

Cara Therapeutics News - From Partners

CARA Stockcharts

View CARA PE ratio, PS ratio stocks charts and compare with peers.
CARA Chart
Note: Compare Cara Therapeutics stock price history with the index and industry peers.

Cara Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Cara Therapeutics Financial Ratios

Receivables Turnover

CARA Industry Peers

Company Price Change (%)
Theratechnologies (THERF)6.10.14 (2.35%)
Syros Pharma (SYRS)16.670.5 (2.91%)
Depomed (DEPO)5.940.05 (0.83%)
Acelrx Pharma (ACRX)3.20 (0%)
Kempharma (KMPH)3.650.15 (3.95%)
Pacira Pharma (PCRX)35.90.2 (0.56%)
Pfizer (PFE)35.990.54 (1.52%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Alnylam Pharma (ALNY)113.8438.8 (51.71%)
Arbutus Biopharma (ABUS)6.71.15 (20.72%)
Amicus Therapeutics (FOLD)14.920.96 (6.88%)
Pluristem Therapeutics (PSTI)1.560.1 (6.85%)
Xoma (XOMA)20.151.16 (6.11%)
Achillion Pharma (ACHN)4.090.23 (5.96%)
The Medicines Company (MDCO)35.661.81 (5.35%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 20, 2017
CompanyPriceChange (%)
MiMedx (MDXG)12.340.82 (6.23%)
NewLink Genetics (NLNK)11.310.57 (4.8%)
Idera Pharma (IDRA)2.220.11 (4.72%)
Athersys (ATHX)2.430.12 (4.71%)
VIVUS (VVUS)0.9490.04 (4.05%)
Verastem (VSTM)5.150.17 (3.2%)
Acceleron Pharma (XLRN)37.731.24 (3.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 20, 2017

Cara Therapeutics Inc Stock News - Partner Headlines

Cara Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues0.08M3.8M3.17M11.96M1.19M
Net Income-57.28M-24.69M-17.74M-3.96M-6.27M
Total Operating Expense58.48M28.99M21.24M12.19M7.41M
View Cara Therapeutics income statement
balance sheet20162015201420132012
Total Assets63.82M110.89M55.93M18.08M5.53M
Total Liabilities13.1M5.85M4.27M6.57M5.14M
Shareholders Equity50.72M105.04M51.66M11.51M0.38M
View Cara Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities5.98M0.16M-1.78M2.43M-0.91M
Net Cash from (used by) Operating Activities-47.38M-21.47M-17.64M2.82M-6.03M
Increase (Decrease) in Prop Plant And Equipment-0.71M-0.02M-0.04M-0.01M0.51M
View Cara Therapeutics cash flow statement

Cara Therapeutics Stock Message Board

An investor needs to spend 13.37 to buy CARA stock, as the closing Cara Therapeutics stock price is 13.37. Cara Therapeutics market capitalization is 439.85M and it represents the total market value of CARA stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Cara Therapeutics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Cara Therapeutics is worth a lot, it will most likely be reflected in an inflated Cara Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 462177 shares were traded with a closing stock price of 13.37 as of 19 Sep, 2017, as can be seen from Cara Therapeutics stock quote. One can view Cara Therapeutics stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. To check the historical stock price movement, all time high, and all time low of CARA, view Cara Therapeutics stock price history.